SEI Investments
GPCR icon

SEI Investments’s Structure Therapeutics GPCR Stock Holding History

SEI Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$674K Sell
13,990
-913
-6% -$62.5K ﹤0.01% 2547
2025
Q4 		$1.04M Buy
+14,903
New +$608K ﹤0.01% 2164
2024
Q3 		– Sell
-5,395
Closed -$212K – 2716
2024
Q2 		$212K Buy
+5,395
New +$222K ﹤0.01% 2441

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SEI Investments's GPCR Position: Q1 2026 in Review

SEI Investments reduced its Structure Therapeutics (GPCR) stake by 6.1% in Q1 2026, selling an estimated $62.5K and leaving 13,990 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

SEI Investments first reported a position in GPCR in Q2 2024 and has held it in 3 quarters since. The position peaked at $1.04M in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • SEI Investments held 13,990 shares of Structure Therapeutics worth $674K as of Q1 2026.
  • SEI Investments sold 913 Structure Therapeutics shares in Q1 2026, an estimated $62.5K.
  • Structure Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2547 holding.
  • SEI Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • SEI Investments's Structure Therapeutics position peaked at $1.04M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.